Profile
Timothy J Pigot is Chief Commercial & Strategy Officer at Inhibikase Therapeutics, Inc. since 2025.
Formerly, Mr. Pigot was Chief Commercial Officer at Jade Biosciences, Inc. from 2021 to 2024.
Education includes undergraduate studies at State University of New York at Binghamton.
Timothy Pigot active positions
| Companies | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 2025-08-18 |
Former positions of Timothy Pigot
| Companies | Position | End |
|---|---|---|
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | 2024-07-31 |
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Timothy Pigot
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
State University of New York at Binghamton
State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
- Stock Market
- Insiders
- Timothy Pigot
















